Disease characteristics, age, and geography are among the main factors that shape first-line treatment patterns in patients ...

For adults with acute myeloid leukemia (AML), pretransplant NPM1 measurable residual disease (MRD) is prognostic for relapse, ...

Physicians who treat sickle cell disease report burnout more often than those who do not, according to results of a ...

After repeated unsuccessful cancer treatments, even the strongest patients can lose hope. But former University of Virginia ...

Key combination for the treatment of first-line AML Recent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) ...

With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood ...

Exposure to petrol compounds appears to be associated with an increased risk of childhood leukemia, including acute lymphoblastic leukemia (ALL), according to a systematic review ...

March 19, 2026. More for You ...

Researchers developed a chip-based platform, “μPharma,” that rapidly predicts drug response through AI analysis for children ...

Key combination for the treatment of first-line AMLRecent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) with iadademstat in combination with venetoclax and aza ...